Scifiniti Publishing served as a Publishing Partner and Exhibitor at the Excellence in Oncology Care (EIOC 2025), which brought together global and regional experts in the field of oncology care. The conference, held at the Event Centre, InterContinental Dubai Festival City, provided a pivotal platform in the Middle East for sharing cutting-edge research and strengthening global collaboration to enhance cancer prevention, diagnosis, and treatment.

The congress welcomed 1,928 in-person attendees from 58 countries, and over 3,987 participants in total, including virtual attendees, reflecting the global significance of the event.

As a Publishing Partner, Scifiniti will provide a dedicated platform through its journal Targeted Cancer Therapy Connect to disseminate pioneering research and clinical insights shared at the conference. Selected abstracts, proceedings, and innovative studies from EIOC 2025 will be considered for publication in the journal at no charge to authors. To further support researchers, Scifiniti will also offer complimentary English language editing and professional graphics enhancement services, ensuring high-quality presentation and global visibility of accepted manuscripts.

At EIOC 2025, Scifiniti was represented by Dr. Eyad Elkord, Editor-in-Chief, and Dr. Mawieh Hamad, Regional Editor, of Targeted Cancer Therapy Connect, along with Qasit Malik, Publishing Director, Mohammad Ghattas, Managing Director, and other members of the Scifiniti team. Together, they actively engaged with attendees, shared insights on publishing opportunities, and highlighted Scifiniti’s commitment to advancing oncology research. Their presence complemented the participation of numerous experts and attendees, fostering meaningful discussions and collaborations throughout the conference.

As an Exhibitor, Scifiniti Publishing welcomed participants to visit its booth, providing an excellent opportunity to meet the team, explore its journals, and discover new avenues for collaboration. EIOC 2025 was held in person from October 31 to November 1, followed by a virtual day on November 2, uniting the global oncology community for dynamic sessions, exhibitions, and inspiring conversations shaping the future of cancer care.